So says Lorenzo Lisi, head of the Workplace Law Group at Aird and Berlis in Toronto, after the Ontario Grievance Settlement ...
This verdict highlights a critical point for practitioners on both sides: liability for retaliation does not depend on the ...
Opinion
The New Republic on MSNThe Trump Administration Is Rushing to Implement SNAP Cuts
It was barely three months ago, on Independence Day, that President Trump signed his so-called One Big Beautiful Bill. The ...
China's weaponization of all-important rare earth minerals is sending the Trump administration scrambling to find new sources ...
Race-neutral pulmonary function testing, now recommended by ATS and implemented at Boston Medical Center, has had a long road ...
When ChatGPT first entered the market, much of the excitement in the go-to-market (GTM) space centered on AI sales ...
The Packers are allowing the fewest yards per pass attempt (5.5) in the NFL, showing the Micah Parsons effect is working.
Arcus Biosciences: Refusing To Let The TIGIT Story Die, And Finding Potential Niches In Huge Markets
Arcus Biosciences is a 'Buy' with strong trial results, robust pipeline, and key phase 3 news coming. Click here to read an analysis of RCUS stock now.
Whether or not Knecht will be able to adapt in the way the Lakers need him to is one of the more important stories of this ...
The dark blue circles on the left side of the graph show the direct measurements of calorie burn during training and racing.
The owner of Amico, a strategic communication and public relations firm, has longtime ties to the nonprofit sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results